Investment Review – October 2019

October 11, 2019 Investment Review

  1. For the month of September, the Dow gained 2%, the S&P advanced 1.7% and the Nasdaq added 0.5%. For the quarter, the Dow and the S&P 500 both rose 1.2%, but the Nasdaq fell 0.1%. Mid-sized companies had a very strong month with a 3.1% increase. Broad based European indices performed slightly better than US, with a 2.5% month, as some Brexit worries were calmed.

  2. The 10-year Treasury note yield was up 17 basis points (bps) for the month, marking its biggest monthly rise since September 2018. The 2-year note yield moved up 12 basis points in the month and the 30-year note yield edged higher to 2.12%. The 30-year bond yield tumbled 41 bps between July and September, marking its biggest quarterly drop in five years.

  3. Following a mid-month attack on a major Saudi Arabian oil processing facility the price of crude oil spiked up about 15%. Assurances from governments and access to strategic reserves calmed shortage fears and the price retreated, ending September down 1.7%.

Key Investment Statistics for October 2019

Sources: Bloomberg LLCFactSet, U.S. Department of LaborDow Jones

Disclosure: This commentary reflects the opinions of Welch & Forbes based on information that we believe to be reliable. It is intended for informational purposes only, and not to suggest any specific performance or results, nor should it be considered investment, financial, tax or other professional advice. It is not an offer or solicitation.

If you would like to receive your copy of the Economic Outlook and Investment Review monthly in the mail, call Ed Sullivan, Vice President, at 617-557-9800, or email him at

Make sure to bookmark our Perspectives webpage so you can stay up to date with the most recent weekly Welch & Forbes insights, announcements, and content. To receive our monthly email digest, simply enter your email address in the banner on this page.

Access your complimentary Wealth Planning Suite

wealth planning suite

Includes your Initial Consultation Portfolio X-Ray© Estate Plan Review Financial Plan

  • This field is for validation purposes and should be left unchanged.

*There is no fee for the Initial Consultation or Portfolio X-Ray© for prospective clients. Portfolio X-Ray© is a Morningstar product that Welch & Forbes maintains a license for its use. The Estate Plan Review and Financial Plan are provided only to clients.